Conference abstract · 10 Aug 2017
Conference abstractPublished 27 Jun 2016
Biosimilar globalization- A silver lining in untested waters
BBCR Consulting, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Twenty-four countries have already approved biosimilars. Some of them, like China and Russia, are not WHO compliant or have developed a biosimilar specific development pathway. Biosimilar authorisation poses a number of substantial scientific and regulatory challenges for local regulatory authorities. Overall, the WHO perspective drives the similar biotherapeutic products globally. The WHO promotes a stepwise comparability exercise indicating that more work is done in pre-clinical comparability, less work is needed in clinical studies. The clinical requirements vary accordingly to existing knowledge of the reference product and the claimed therapeutic indication(s). This presentation focuses on two challenges that, in our opinion, are common across the globe. Clinical studies are necessary to demonstrate comparative efficacy. Special attention should be devoted to immunogenicity which must be always investigated for all products with due consideration to risks in different indications. Clinical Safety is to be monitored closely via risk specification and pharmacovigilance plan (PV). From a regulatory perspective, a risk management plan (RMP) or PV plan requirements do not differ in biosimilars from other biologic therapeutics. Extrapolation of safety and efficacy data is justified from one indication to another with a comprehensive comparability program with the innovator and when the target receptor and the mechanism of action are identical. We reckon it critical to discuss extrapolation of data in the context of major changes in the manufacturing process of the originator biologicals. In such situations, the clinical data and the overall information of the exercise from one indication could be allowed to other indication extrapolation.
Subjects
Environmental & Earth SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2013
Global Assessment of Silver Pollution using Sperm Whales (Physeter macrocephalus) as an Indicator Species
Conference abstract
Global Assessment of Silver Pollution using Sperm Whales (Physeter macrocephalus) as an Indicator Species
Conference abstract
Global Assessment of Silver Pollution using Sperm Whales (Physeter macrocephalus) as an Indicator Species
Conference abstract
Global Assessment of Silver Pollution using Sperm Whales (Physeter macrocephalus) as an Indicator Species
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectEnvironmental & Earth Sciences
- BylineArticles whose byline prints “Candida Fratazzi”
